Novel nanomedicine with a chemical-exchange saturation transfer effect for breast cancer treatment in vivo

[1] Chamberlain FE(2019)Aldoxorubicin in soft tissue sarcomas Future Oncol 15 1429-1435

[2] Jones RL(2018)Assessment of chemotherapy on various biochemical markers in breast cancer patients J Cell Biochem 119 2923-2928

[3] Chawla SP(2017)Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles Drug Deliv 24 1482-1490

[4] Paz M(2018)The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity Eur J Pharm Sci 121 118-125

[5] Gomes ALJ(2016)Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy Int J Nanomed 11 4545-4552

[6] Islam MT(2018)Nano based drug delivery systems: recent developments and future prospects J Nanobiotechnol 16 71-1293

[7] Tabrez S(2016)Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy J Nanobiotechnol 14 39-59

[8] Jabir NR(2015)Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer ACS Nano 9 1280-22

[9] Alam MZ(2014)A diaCEST MRI approach for monitoring liposomal accumulation in tumors J Control Release 180 51-42

[10] Machado KC(2015)Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography J Nanobiotechnol 13 90-3762

[1] Chamberlain FE(2019)Aldoxorubicin in soft tissue sarcomas Future Oncol 15 1429-1435

[2] Jones RL(2018)Assessment of chemotherapy on various biochemical markers in breast cancer patients J Cell Biochem 119 2923-2928

[3] Chawla SP(2017)Targeted inhibition of human hematological cancers in vivo by doxorubicin encapsulated in smart lipoic acid-crosslinked hyaluronic acid nanoparticles Drug Deliv 24 1482-1490

[4] Paz M(2018)The effect of size and polymer architecture of doxorubicin-poly(ethylene) glycol conjugate nanocarriers on breast duct retention, potency and toxicity Eur J Pharm Sci 121 118-125

[5] Gomes ALJ(2016)Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy Int J Nanomed 11 4545-4552

[6] Islam MT(2018)Nano based drug delivery systems: recent developments and future prospects J Nanobiotechnol 16 71-1293

[7] Tabrez S(2016)Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy J Nanobiotechnol 14 39-59

[8] Jabir NR(2015)Nanohybrid liposomal cerasomes with good physiological stability and rapid temperature responsiveness for high intensity focused ultrasound triggered local chemotherapy of cancer ACS Nano 9 1280-22

[9] Alam MZ(2014)A diaCEST MRI approach for monitoring liposomal accumulation in tumors J Control Release 180 51-42

[10] Machado KC(2015)Tumor specific liposomes improve detection of pancreatic adenocarcinoma in vivo using optoacoustic tomography J Nanobiotechnol 13 90-3762